Safe, no link to sudden deaths: Covishield maker after Siddaramaiah's vaccine remark
After Karnataka chief minister Siddaramaiah linked the recent heart attack deaths in Hassan district to the Covid-19 vaccines, Covishield's maker, Serum Institute of India, has denied such a connection and said that it is "safe and scientifically validated". Karnataka CM Siddaramaiah had also said that the Covid-19 vaccines were "hastily" approved.(Bloomberg)
The vaccine maker has backed the statement given by the ministry of health, which cited two large-scale studies by ICMR and AIIMS to affirm that no links have been found between Covid-19 vaccines and sudden deaths.
"In light of recent concerns, we affirm: Two large-scale studies by ICMR and AIIMS, as cited by the Ministry of Health (@MoHFW_INDIA) have found no link between COVID-19 vaccines and sudden deaths. The vaccines are safe and scientifically validated," SII said in a post on its X handle.
Congress leader and Karnataka CM Siddaramaiah had said that the vaccines were "hastily" approved, adding that the recent heart attack deaths in Hassan may be linked to the vaccination drive.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
38 minutes ago
- The Hindu
Medical experts call for increased vaccination to tackle HPV-associated cancers
Medical professionals at a conclave in Coimbatore on Friday urged greater uptake of the Human Papillomavirus (HPV) vaccine to prevent cervical and other HPV-associated cancers. The awareness campaign was launched as part of a nationwide public health initiative led by the Serum Institute of India (SII). The panel comprised T.V. Chitra Bhat, Professor and Unit Head, PSG Institute of Medical Sciences and Research (PSG IMS&R); K. Aarathy, MD, Manu Hospital; P. Senthil Kumar, Senior Assistant Professor, Neonatology, Coimbatore Medical College Hospital; A. Jayavardhana, Professor and Head, PSG IMS&R and N. Jayashree, Associate Professor, Cancer Institute, Adyar. The discussion was moderated by Nandhini Kumaran, Consultant, Masonic Hospital and Sri Ramakrishna Hospital. The experts highlighted the need to raise awareness among adolescents and parents and underscored the responsibility of healthcare providers in promoting preventive care. They pointed out that although a safe and effective vaccine is available, uptake remains low in India. 'HPV is not limited to cervical cancer alone. It is also associated with cancers of the vulva, vagina, anus, penis, and oropharynx, affecting both men and women,' said Dr. Senthil Kumar. 'With peak HPV infection occurring between ages 15 and 25, early awareness and timely preventive action are essential. With the availability of Cervavac, an affordable HPV vaccine developed in India, it has become easier to protect individuals from HPV-associated cancers.' During the conclave, the panel noted that India continues to face a high burden of HPV-related diseases, with cervical cancer being the second most common cancer among women. According to the ICO/IARC Information Centre on HPV and Cancer (2023), India reports over 1.23 lakh new cervical cancer cases and more than 77,000 related deaths annually. HPV is also linked to up to 90% of anal cancers and 63% of penile cancers, they said. The experts said limited public knowledge, stigma around discussing sexually transmitted infections, and the absence of routine vaccine recommendations in clinical settings are major reasons for the low coverage.
India Gazette
41 minutes ago
- India Gazette
Nipah virus alert issued in three Kerala districts after two suspected cases
Thiruvananthapuram (Kerala) [India], July 4 (ANI): Health authorities in Kerala have issued an alert in three districts -- Kozhikode, Malappuram and Palakkad after two suspected cases of the Nipah virus were detected. Kerala Health Minister Veena George said that the suspected cases of Nipah virus are from Palakkad and Malappuram districts. 'An alert has been issued in three districts of Kerala, namely Kozhikode, Malappuram and Palakkad, in connection with two new Nipah virus cases,' she said. The tests conducted at medical college hospitals in Malappuram and Kozhikode have confirmed the infections. Samples have also been sent to the National Institute of Virology (NIV) in Pune for further confirmation. Even as a final confirmation is awaited, the government has directed officials to strengthen preventive measures to contain the spread of the virus. The Health Minister said that 26 committees have been formed across districts to coordinate the response. Police support will be sought to prepare a contact list, and state and district-level helplines will be activated. District Collectors have been directed to make arrangements for declaring containment zones if required. The National Institute of Virology (NIV), Pune, is the only lab in the country that cultures the Nipah virus. The virus, which is zoonotic in nature (transmitted from animals to humans), can also spread through contaminated food or directly between people. The symptoms of the Nipah virus are fever, headaches, muscle pain, vomiting, sore throat, dizziness, altered consciousness, and Atypical pneumonia. In infected people, it causes a range of illnesses from asymptomatic (subclinical) infection to acute respiratory illness and fatal encephalitis. Nipah Virus Disease (NiVD) has a mortality rate of 50 per cent, making it one of the most dangerous viral diseases. The Indian Council of Medical Research (ICMR) developed RAMBAAN, a Mobile BSL-3 [MBSL-3] laboratory, an innovative initiative for providing the diagnostic surge capacity for enhancing the onsite laboratory services during the outbreaks of known and unknown high-risk pathogens. RAMBAAN, a Made-in-India rapid action mobile lab, was also deployed in response to the Nipah virus outbreak in Kerala in 2023 and 2024. 'The MBSL-3 was successfully deployed and operationalised for the first time in response to the Nipah virus (NiV) outbreak in Kozhikode, Kerala, India, in September 2023 and again in Malappuram District of Kerala state in July 2024,' said ICMR. This 'laboratory on wheels' represents a significant advancement in outbreak investigation and public health emergency response in India. The ICMR is also working on an indigenous vaccine for the Nipah virus. (ANI)
Time of India
2 hours ago
- Time of India
Dhami govt marks 4 Years with healthcare push: Hospitals begin operations in Pithoragarh & Rudrapur; two new medical colleges in pipeline
NEW DELHI: As the Pushkar Singh Dhami-led government marks four years in office, Uttarakhand is poised to receive two new government medical colleges, in Pithoragarh and Rudrapur. Tired of too many ads? go ad free now Ahead of the launch, hospital operations have already begun at both sites, setting the groundwork for future academic and healthcare services. Since taking office on July 4, 2021, chief minister Pushkar Singh Dhami has focused heavily on strengthening the state's medical infrastructure. During his tenure, two government medical colleges have already been made operational, Almora Medical College in 2021 and Haridwar Medical College in 2024. These institutions have added 200 MBBS seats, raising the total number of first-year medical seats in the state to 625. Prior to these additions, government medical colleges were already functioning in Srinagar, Dehradun, and Haldwani. The government now aims to expedite the construction of the upcoming colleges in Pithoragarh and Rudrapur. According to Dr. Ashutosh Sayana, director of medical education, hospitals at both locations are already operational, and work is underway to ensure adequate staffing and infrastructure to support the upcoming medical colleges. Progress on AIIMS Satellite and Cancer Hospital In a major boost to tertiary healthcare, an AIIMS satellite center in Kichha was also approved during Dhami's tenure and work on it is progressing rapidly. The state has also launched its first air ambulance service through AIIMS Rishikesh, catering to emergency medical needs. Additionally, a 300-bed cancer hospital in Harrawala, Dehradun, has been completed. Ayushman Scheme a Lifeline for Patients The Atal Ayushman Uttarakhand Yojana has emerged as a crucial support system for underprivileged families. Tired of too many ads? go ad free now Under the scheme, eligible cardholders receive free treatment up to ₹5 lakh per year for critical illnesses like heart disease, kidney disorders, cancer, and diabetes. So far, around 60 lakh Ayushman cards have been issued in the state. Beneficiaries can avail of treatment in over 30,000 reputed government and private hospitals across India. Highlighting the government's commitment, chief minister Dhami said, 'In hilly areas, people had to travel to big cities even for minor ailments. Our aim is to create a strong healthcare network at the district and tehsil levels. New medical colleges will ensure better treatment for people and open new career opportunities for youth in the medical field.' With a clear focus on decentralizing healthcare and expanding medical education, the Dhami government is making notable strides in transforming Uttarakhand's health landscape.
